These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 27149321)

  • 1. Visualization of hepatitis B virus entry - novel tools and approaches to directly follow virus entry into hepatocytes.
    Zhang Z; Zehnder B; Damrau C; Urban S
    FEBS Lett; 2016 Jul; 590(13):1915-26. PubMed ID: 27149321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes.
    Ni Y; Lempp FA; Mehrle S; Nkongolo S; Kaufman C; Fälth M; Stindt J; Königer C; Nassal M; Kubitz R; Sültmann H; Urban S
    Gastroenterology; 2014 Apr; 146(4):1070-83. PubMed ID: 24361467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies to inhibit entry of HBV and HDV into hepatocytes.
    Urban S; Bartenschlager R; Kubitz R; Zoulim F
    Gastroenterology; 2014 Jul; 147(1):48-64. PubMed ID: 24768844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Tricyclic Polyketide, Vanitaracin A, Specifically Inhibits the Entry of Hepatitis B and D Viruses by Targeting Sodium Taurocholate Cotransporting Polypeptide.
    Kaneko M; Watashi K; Kamisuki S; Matsunaga H; Iwamoto M; Kawai F; Ohashi H; Tsukuda S; Shimura S; Suzuki R; Aizaki H; Sugiyama M; Park SY; Ito T; Ohtani N; Sugawara F; Tanaka Y; Mizokami M; Sureau C; Wakita T
    J Virol; 2015 Dec; 89(23):11945-53. PubMed ID: 26378168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B Virus Entry into Cells.
    Herrscher C; Roingeard P; Blanchard E
    Cells; 2020 Jun; 9(6):. PubMed ID: 32570893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium taurocholate cotransporting polypeptide acts as a receptor for hepatitis B and D virus.
    Yan H; Li W
    Dig Dis; 2015; 33(3):388-96. PubMed ID: 26045274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (-)-Epigallocatechin-3-gallate inhibits entry of hepatitis B virus into hepatocytes.
    Huang HC; Tao MH; Hung TM; Chen JC; Lin ZJ; Huang C
    Antiviral Res; 2014 Nov; 111():100-11. PubMed ID: 25260897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 6 inhibits HBV entry through NTCP down regulation.
    Bouezzedine F; Fardel O; Gripon P
    Virology; 2015 Jul; 481():34-42. PubMed ID: 25765005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The p.Ser267Phe variant of sodium taurocholate cotransporting polypeptide (NTCP) supports HBV infection with a low efficiency.
    Liu C; Xu G; Gao Z; Zhou Z; Guo G; Li D; Jing Z; Sui J; Li W
    Virology; 2018 Sep; 522():168-176. PubMed ID: 30032030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From DCPD to NTCP: the long journey towards identifying a functional hepatitis B virus receptor.
    Li J; Tong S
    Clin Mol Hepatol; 2015 Sep; 21(3):193-9. PubMed ID: 26523264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of the bile acid transporter and hepatitis B virus receptor Na+/taurocholate cotransporting polypeptide (NTCP) in hepatocytes.
    König A; Döring B; Mohr C; Geipel A; Geyer J; Glebe D
    J Hepatol; 2014 Oct; 61(4):867-75. PubMed ID: 24845614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium taurocholate cotransporting polypeptide inhibition efficiently blocks hepatitis B virus spread in mice with a humanized liver.
    Nakabori T; Hikita H; Murai K; Nozaki Y; Kai Y; Makino Y; Saito Y; Tanaka S; Wada H; Eguchi H; Takahashi T; Suemizu H; Sakamori R; Hiramatsu N; Tatsumi T; Takehara T
    Sci Rep; 2016 Jun; 6():27782. PubMed ID: 27278060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP).
    Watashi K; Sluder A; Daito T; Matsunaga S; Ryo A; Nagamori S; Iwamoto M; Nakajima S; Tsukuda S; Borroto-Esoda K; Sugiyama M; Tanaka Y; Kanai Y; Kusuhara H; Mizokami M; Wakita T
    Hepatology; 2014 May; 59(5):1726-37. PubMed ID: 24375637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NTCP opens the door for hepatitis B virus infection.
    Yan H; Liu Y; Sui J; Li W
    Antiviral Res; 2015 Sep; 121():24-30. PubMed ID: 26071008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP.
    Iwamoto M; Watashi K; Tsukuda S; Aly HH; Fukasawa M; Fujimoto A; Suzuki R; Aizaki H; Ito T; Koiwai O; Kusuhara H; Wakita T
    Biochem Biophys Res Commun; 2014 Jan; 443(3):808-13. PubMed ID: 24342612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor.
    Nkongolo S; Ni Y; Lempp FA; Kaufman C; Lindner T; Esser-Nobis K; Lohmann V; Mier W; Mehrle S; Urban S
    J Hepatol; 2014 Apr; 60(4):723-31. PubMed ID: 24295872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of HBV transcription by sodium taurocholate cotransporting polypeptide at the postentry step is inhibited by the entry inhibitor Myrcludex B.
    Zhao K; Liu S; Chen Y; Yao Y; Zhou M; Yuan Y; Wang Y; Pei R; Chen J; Hu X; Zhou Y; Zhao H; Lu M; Wu C; Chen X
    Emerg Microbes Infect; 2018 Nov; 7(1):186. PubMed ID: 30459339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of hepatitis B virus attachment and entry.
    Lempp FA; Urban S
    Intervirology; 2014; 57(3-4):151-7. PubMed ID: 25034482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Entry of hepatitis B and hepatitis D virus into hepatocytes: Basic insights and clinical implications.
    Li W; Urban S
    J Hepatol; 2016 Apr; 64(1 Suppl):S32-S40. PubMed ID: 27084034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irbesartan, an FDA approved drug for hypertension and diabetic nephropathy, is a potent inhibitor for hepatitis B virus entry by disturbing Na(+)-dependent taurocholate cotransporting polypeptide activity.
    Wang XJ; Hu W; Zhang TY; Mao YY; Liu NN; Wang SQ
    Antiviral Res; 2015 Aug; 120():140-6. PubMed ID: 26086883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.